PAPER Chang CH, Wang HE, Liaw PY, Peng CC, Peng RY
SEARCH RESULTS
330026 RESULTS
PAPER Rodríguez-Martínez AB, de Munain AL, Ferrer I, Zarranz JJ, Atarés B, Villagra NT, Arteagoitia JM, Garrido JM, Juste RA
Coexistence of protease sensitive and resistant prion protein in 129VV homozygous sporadic Creutzfeldt-Jakob disease: a case report.
J Med Case Rep. 2012;6(1):348. PubMed: 23057723PAPER Abelein A, Lang L, Lendel C, Gräslund A, Danielsson J
Transient small molecule interactions kinetically modulate amyloid β peptide self-assembly.
FEBS Lett. 2012 Nov 16;586(22):3991-5. PubMed: 23058290PAPER Pattanayak RD, Jena R, Tripathi M, Khandelwal SK
Assessment of burden in caregivers of Alzheimer's disease from India.
Asian J Psychiatr. 2010 Sep;3(3):112-6. PubMed: 23051566PAPER Vann A
Listen more carefully to Alzheimer's caregivers.
J Am Geriatr Soc. 2012 Oct;60(10):2000. PubMed: 23057467PAPER Kakuda N, Akazawa K, Hatsuta H, Murayama S, Ihara Y,
Suspected limited efficacy of γ-secretase modulators.
Neurobiol Aging. 2012 Oct 8; PubMed: 23058852PAPER Tweedie D, Rachmany L, Rubovitch V, Lehrmann E, Zhang Y, Becker KG, Perez E, Miller J, Hoffer BJ, Greig NH, Pick CG
Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.
Exp Neurol. 2013 Jan;239:170-82. Epub 2012 Oct 8 PubMed: 23059457PAPER Atkins ER, Bulsara MK, Panegyres PK
The natural history of early-onset dementia: the Artemis Project.
BMJ Open. 2012;2(5) PubMed: 23059847PAPER Cimini A, Gentile R, Angelucci F, Benedetti E, Pitari G, Giordano A, Ippoliti R
Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease model.
J Cell Biochem. 2012 Oct 11; PubMed: 23060010PAPER Ntelios D, Berninger B, Tzimagiorgis G
Numb and Alzheimer's disease: the current picture.
Front Neurosci. 2012;6:145. PubMed: 23060745PAPER Singh B, Sharma B, Jaggi AS, Singh N
Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property.
J Renin Angiotensin Aldosterone Syst. 2012 Oct 11; PubMed: 23060470PAPER Lu Y
Integrating experimentation and quantitative modeling to enhance discovery of Beta amyloid lowering therapeutics for Alzheimer's disease.
Front Pharmacol. 2012;3:177. PubMed: 23060797PAPER Friedland RP, Shah JJ, Farrer LA, Vardarajan B, Rebolledo-Mendez JD, Mok K, Hardy J
Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat.
Front Neurol. 2012;3:136. PubMed: 23060854PAPER Li X, Lv Y, Yu S, Zhao H, Yao L
The effect of cadmium on Aβ levels in APP/PS1 transgenic mice.
Exp Ther Med. 2012 Jul;4(1):125-130. PubMed: 23060935PAPER Lykou E, Rankin KP, Chatziantoniou L, Boulas C, Papatriantafyllou O, Tsaousis I, Neuhaus J, Karageorgiou C, Miller BL, Papatriantafyllou JD
Big 5 Personality Changes in Greek bvFTD, AD, and MCI Patients.
Alzheimer Dis Assoc Disord. 2012 Oct 10; PubMed: 23060360Current Filters
No filters selected